On Oct 10, major Wall Street analysts update their ratings for $Accolade (ACCD.US)$, with price targets ranging from $5 to $8.
Morgan Stanley analyst Craig Hettenbach maintains with a hold rating, and maintains the target price at $6.
Barclays analyst Stephanie Davis maintains with a hold rating, and maintains the target price at $5.
Truist Financial analyst Jailendra Singh maintains with a buy rating, and sets the target price at $7.5.
Stephens analyst Jeffrey Garro maintains with a buy rating, and adjusts the target price from $11 to $8.
Furthermore, according to the comprehensive report, the opinions of $Accolade (ACCD.US)$'s main analysts recently are as follows:
The second quarter results echo persistent themes within the business, such as enhancing profitability alongside a moderation in revenue expansion. The projections for fiscal year 2025 have been revised, with a decrease in revenue and adjusted EBITDA estimates post-report. This adjustment is due to anticipated lower growth in PlushCare and throughout the broader business model, which consequently impacts EBITDA expectations.
The shares of Accolade are experiencing an uptick following the fiscal Q2 report, backed by sustained fiscal 2025 guidance, encouraging comments about the selling season, and clear insights into a significant Q4 increase. Although the near-term environment may present challenges for securing new employer agreements, the company's sharpened emphasis on profitable expansion is seen in a favorable light.
Here are the latest investment ratings and price targets for $Accolade (ACCD.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月10日，多家華爾街大行更新了$Accolade (ACCD.US)$的評級，目標價介於5美元至8美元。
摩根士丹利分析師Craig Hettenbach維持持有評級，維持目標價6美元。
巴克萊銀行分析師Stephanie Davis維持持有評級，維持目標價5美元。
儲億銀行分析師Jailendra Singh維持買入評級，目標價7.5美元。
Stephens分析師Jeffrey Garro維持買入評級，並將目標價從11美元下調至8美元。
此外，綜合報道，$Accolade (ACCD.US)$近期主要分析師觀點如下：
第二季度的業務成果反映了業務內持久的主題，如在營收擴張適度減緩的同時增強盈利能力。 2025財年的預測已經修訂，預計營收和調整後的EBITDA估計在報告後有所下降。這一調整是由於 PlushCare 和整體業務模式預期增長較低，從而影響了EBITDA預期的影響。
Accolade的股票在財季Q2報告後出現上升，受持續的2025財年指導、對銷售季節的鼓舞人心的評價以及對四季度增長的明確洞察的支持。 儘管短期環境可能會對獲得新僱主協議帶來挑戰，但公司對盈利擴張的強調愈發受到青睞。
以下爲今日4位分析師對$Accolade (ACCD.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
